Fresenius SE & Co.KGaA

Tweet this page
<
2019
2020
2021
2022
2023
2024
>
Registration as it was on 29 Feb 2024
How to read and use this data card.
Download this datacard

Overview

Lobbying Costs

300,000€ - 399,999€

Financial year: Jan 2022 - Dec 2022

Lobbyists (Full time equivalent)

1.25 Fte (2)

Lobbyists with EP accreditation

1

High-level Commission meetings

1

Lobbying Costs over the years

  • Info

    Fresenius SE & Co.KGaA   (FSE)

    EU Transparency Register

    047428334069-39 First registered on 22 Feb 2019

    Goals / Remit

    Fresenius SE & Co. KGaA (Frankfurt/Xetra: FRE) is a global healthcare company headquartered in Bad Homburg v. d. Höhe, Germany. In the 2023 fiscal year, Fresenius generated €22.3 billion in annual revenue with its more than 190,000 employees.
    Fresenius offers solutions to the social challenges posed by a growing and ageing population and the resulting need for affordable, high-quality healthcare.
    The Fresenius Group comprises the operating companies Fresenius Kabi and Fresenius Helios as well as the investment companies Fresenius Vamed and Fresenius Medical Care. With 140 hospitals and countless outpatient facilities, Fresenius Helios is the leading private hospital operator in Germany and Spain, treating around 26 million patients every year. Fresenius Kabi’s product portfolio includes a range of highly complex biopharmaceuticals, clinical nutrition, medical technology, and generic intravenous drugs.

    Main EU files targeted

    Artificial Intelligence, Biosimilars, Chemical Regulations, Chemicals Strategy for Sustainability, Chronic Diseases, Circular Economy, Corporate Sustainability Due Dilligence, Environmental Policies, EU Green Deal, EU Trade Policy, European Cancer Plan, European Health Data Space, European Semester, Equal Pay Directive, Free Trade Agreements, Global Gateway Initiative, Global Health Policies, Health Technology Assessment, Horizon Europe Programme, Hospitals, Industrial Strategy, IP Legislation, Multiannual Financial Framework, Network and Information Security, Patients, Pricing and Reimbursement Policies, Public Health Policies, Raw Materials Act, REACH, Revision of Directive 2001/83/EC, Revision of Medical Device Regulation, Standardisation, Taxonomy, Waste Water, Zero Net Industry Act

    Address

    Head Office
    Else-Kröner-Str. 1
    Bad Homburg 61352
    GERMANY
    EU Office
    21, Rue Montoyer
    Brüssel 1000
    BELGIUM

    Website

    http://fresenius.com

  • People

    Total lobbyists declared

    2

    Employment timeLobbyists
    100%1
    25%1

    Lobbyists (Full time equivalent)

    1.25

    Lobbyists with EP accreditation

    All Lobbyists with EP accreditation over time

    1 accreditations were / are live (in bold) for the selected state of 08 May 2024

    Name Start date End Date
    Filip Julius LASSAHN 14 Sep 2023 13 Sep 2024
    Filip Julius LASSAHN 21 Sep 2022 14 Sep 2023
    Filip Julius LASSAHN 09 Sep 2021 10 Sep 2022
    Filip Julius LASSAHN 17 Dec 2019 17 Dec 2020
    Ms Eleni MARAGKAKI 16 Jul 2019 13 Dec 2019

    Complementary Information

    None declared

    Person in charge of EU relations

    Data not provided by Register Secretariat due to GDPR

    Person with legal responsibility

    Data not provided by Register Secretariat due to GDPR

  • Categories

    Category

    Companies & groups

  • Networking

    Affiliation

    Fresenius SE & Co.KGaA and its consolidated subsidiaries are represented in a large number of associations worldwide.

    Memberships of Fresenius SE & Co.KGaA in organisations that would be relevant for the register are as follows:
    - MedTech Europe
    - Bundesverband der Arzneimittel-Hersteller e.V. (BAH)
    - Bundesverband Medizintechnologie e. V. (BVmed)
    - German Health Alliance (GHA)
    - Deutsches Institut für Normung e. V. (DIN)

    Relevant Memberships of Fresenius Kabi Deutschland GmbH can be found in the independet registry entry.

    Member organisations

    None declared

  • Financial Data

    Interests represented

    Promotes their own interests or the collective interests of their members

    Closed financial year

    Jan 2022 - Dec 2022

    Lobbying costs for closed financial year

    300,000€ - 399,999€

    Major contributions in closed year

    None declared

    Intermediaries for closed year

    None declared

    Intermediaries for current year

    None declared

    Closed year Costs

    300,000€ - 399,999€

    Other financial info

    Please note that Fresenius Kabi Deutschland GmbH has its own entry in the Transparency Register (Identification number: 130305227617-65). All information given and registered values relate only to Fresenius SE & Co. KGaA.

  • EU Structures

    Groups (European Commission)

    none

    Groups (European Parliament)

    N/A

    Communication activities

    None

    Other activities

    None declared

  • Meetings

    Meetings

    1 meetings found. Download meetings

    The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.

    • Date 05 Mar 2024 Location Brussels
      Subject Strengthen Europe's critical sectors
      Cabinet Cabinet of Executive Vice-President Valdis Dombrovskis
      Attending
      • Michael Hager (Cabinet member)
Download this datacard